What we do Kilitch Drugs (India) Ltd is a global pharmaceutical company manufacturing and marketing diverse formulations across solid, liquid, and parenteral dosage forms. |
Founded in 1,992 |
Market share One of India's most reliable injectable manufacturers and largest cephalosporin producers in Africa with global export presence. |
Problem solved Provides safe, quality pharmaceutical solutions for chronic and acute conditions including sterile injectables and nutraceuticals. |
Top clients or who we serve Serves pharmaceutical distributors and healthcare providers globally including markets in India, Africa, Middle East, and Americas - B2B focused. |
Key management - |
Our journey and innovations Public since 1994; expanded production through rights issue; set up plants in India, Yemen and Ethiopia; pioneered export contracts to Americas and Africa. |
Where we operate India, Ethiopia, Yemen, Africa, Middle East, South & Central America. |
Top products or what we offer Pharmaceutical formulations including tablets, capsules, injectables, effervescent tablets, OTC nutraceuticals, cosmetics, and medical devices. |
Top brands BENIN (launched 2011); Clue-Plus; Bon-Bon Gripe Water; Kilitch Balm; Sterile injectables and cephalosporins as key revenue drivers. |
Raw materials needed Active pharmaceutical ingredients (APIs), excipients for formulations across dosage forms. |
Raw materials supplier Sourced from global and local suppliers; Company also manufactures some APIs in-house. |
Recurring vs cyclical contribution Majority recurring revenue from pharmaceutical formulation sales with steady operational demand. |
Our industry position Leading injectable manufacturer in India, largest cephalosporin maker in Africa with diversified global exports. |
Financial highlights FY 2024-25 consolidated revenue Rs. 198.32 crore; net profit Rs. 26.7 crore; steady growth over previous year. |
Geographical revenue split Significant revenue from exports to Africa, Middle East, Americas and strong domestic presence in India. |
Order book - |
Whats driving growth Innovation in sterile injectables, expanded global footprint, sustained export growth and product diversification. |
Our future plans Right issue planned to raise ~Rs. 50 crore for capacity expansion and market development. |
Our green promise Energy optimization through efficient power usage with continuous efforts on conservation and operational improvements. |
Our people and values Experienced management, promoting transparency, governance and compliance with employee welfare policies. |
Key challenges ahead Maintaining regulatory compliance across markets, managing raw material costs, and competitive pharmaceutical landscape. |
Interesting facts First Indian firm to set up pharmaceutical plant in Yemen; major supplier of cephalosporins to Africa. |
Risks and strategy Mitigate regulatory and market risks via diversification, strong governance, and continuous R&D investment. |
